These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27087351)

  • 41. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D; Karavani G; Hirsch HJ; Strich D
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty.
    Omar AA; Nyaga G; Mungai LNW
    Int J Pediatr Endocrinol; 2020 Dec; 2020(1):22. PubMed ID: 33292495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
    Weise M; Flor A; Barnes KM; Cutler GB; Baron J
    J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
    Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
    [No Abstract]   [Full Text] [Related]  

  • 46. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
    Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
    Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Long-term therapy with delayed-action LHRH-antagonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study].
    Sippell WG; Partsch CJ; Hümmelink R; Lorenzen F
    Gynakologe; 1991 Apr; 24(2):108-13. PubMed ID: 1835952
    [No Abstract]   [Full Text] [Related]  

  • 48. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperprolactinemia after treatment of long-acting gonadotropin-releasing hormone analogue Decapeptyl in girls with central precocious puberty.
    Kauschansky A; Nussinovitch M; Frydman M; Yeshaya A; Ben-Rafael Z
    Fertil Steril; 1995 Aug; 64(2):285-7. PubMed ID: 7615104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different effects of agonistic vs. antagonistic gnrh-analogues (triptorelin vs. cetrorelix) on bone modeling and remodeling in peripubertal female rats.
    Roth CL; Neu C; Jarry H; Schoenau E
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):451-6. PubMed ID: 16151979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Indications of GnRH agonist therapy during childhood].
    Carel JC
    Bull Acad Natl Med; 2012 Feb; 196(2):345-55. PubMed ID: 23420954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
    Sørensen K; Andersson AM; Skakkebaek NE; Juul A
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
    J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local reactions to luteinizing hormone releasing hormone analog therapy.
    Tonini G; Marinoni S; Forleo V; Rustico M
    J Pediatr; 1995 Jan; 126(1):159-60. PubMed ID: 7815213
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triptorelin depot stimulation test for central precocious puberty.
    Strich D; Kvatinsky N; Hirsch HJ; Gillis D
    J Pediatr Endocrinol Metab; 2013; 26(7-8):631-4. PubMed ID: 23425599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GnRH agonist treatment in girls with precocious puberty does not compromise post-pubertal uterine size.
    Ben-Haroush A; Goldberg-Stern H; Phillip M; de Vries L
    Hum Reprod; 2007 Mar; 22(3):895-900. PubMed ID: 17172284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudotumor cerebri caused by all-trans-retinoic acid: a case report.
    Tiamkao S; Sirijirachai C
    J Med Assoc Thai; 2000 Nov; 83(11):1420-3. PubMed ID: 11215876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An overview of LHRH and its analogues: clinical uses.
    Crowley WF
    Ups J Med Sci; 1984; 89(1):3-12. PubMed ID: 6377638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.